American Pharmacists Association (APhA)
FDANonrulemakingFDA-2016-D-1233

Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics; Draft Guidance for Stakeholders and Food and Drug Administration Staff; Availability

RIN
Last modified
Apr 17, 2018
Comment window
closed 3582d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Oct 18, 2016 and Oct 18, 2016. 15 other organizations filed here. The comment window closed 3582d ago.

What American Pharmacists Association (APhA) filed (1)

Oct 18, 2016· Comment from American Pharmacists Association (APhA)· FDA-2016-D-1233-0026

Please see attached for comments from the American Pharmacists Association

Abstract

No abstract recorded.

View on regulations.gov →